CDC issues recommendation for Truvada

Share this article:

The CDC issued a recommendation that Americans at risk for AIDS take Gilead's Truvada, a daily pill that has demonstrated it can prevent the infection.

The New York Times conjectures that if this advice is followed, this could signal a shift in AIDS prevention, from condom usage to Truvada and “would mean a 50-fold increase in the number of prescriptions” for the drug.

It also suggests that CDC's statement may have been due to a recent CDC survey in November that showed  condom use is going down, with a 20% rise from 2005 to 2011 in gay men reporting unprotected sex.

This isn't the first time that the NYT has written about the drug's acceptance either. In December of 2013, the paper offered readers an explanation for the drug's low uptake among the gay community.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Imbruvica lassoes CLL indication

The FDA slapped a Breakthrough Therapy label on the CLL indication pursuit in February.

FDA asks social media "how'm I doin?"

The FDA's Center for Drug Evaluation and Research's Office of Communications wants a system that will help assess its messaging reach across the interwebs and its many forums.

Reckitt Benckiser wants out of pharma

The company plans to spin off its pharmaceutical unit.